Loading...
Ginkgo Bioworks Holdings, Inc. WT
DNA-WT•NYSE
HealthcareBiotechnology
$0.27
$-0.01(-2.76%)
Ginkgo Bioworks Holdings, Inc. WT (DNA-WT) Stock Overview
Explore Ginkgo Bioworks Holdings, Inc. WT’s financial performance, market position, analyst ratings, and future outlook.
Revenue Growth
-9.71%
↓ 9.71%
Profit Growth
$-8.70
↑ 38.73%
EPS Growth
$-8.70
↑ 42.62%
Operating Margin
-198.27%
↑ 35.24%
ROE
-63.06%
↑ 38.73%
Dividend Yield
0.00%
Analyst Recommendations data is not available for DNA-WTAnalyst Recommendations details for DNA-WT are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile data is not available for DNA-WTCompany Profile details for DNA-WT are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.